News The latest updates on Longhorn. Van Agens 11/13/24 Van Agens 11/13/24 Longhorn Vaccines and Diagnostics Composite Peptide Vaccine Combats Sepsis Related to Antimicrobial Resistant Tuberculosis Read More Van Agens 10/16/24 Van Agens 10/16/24 Longhorn Vaccines and Diagnostics Highlights New Data for LHNVD-303 its Bacterial Sepsis Vaccine at IDWeek 2024 Read More Van Agens 9/30/24 Van Agens 9/30/24 Longhorn Vaccines and Diagnostics Collaborates with Institute of Agrifood Research and Technology on Research to Inactivate Swine Fever During Sample Collection Process Read More Van Agens 7/31/24 Van Agens 7/31/24 Longhorn Vaccines and Diagnostics Provides Mid-Year Progress on Vaccine and Diagnostic Divisions Read More Van Agens 6/4/24 Van Agens 6/4/24 Longhorn Vaccines and Diagnostics to Showcase PrimeStore® Molecular Transport Medium at Two European Veterinary Health Conferences Read More Van Agens 4/27/24 Van Agens 4/27/24 Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024 Read More Van Agens 4/11/24 Van Agens 4/11/24 Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024 Read More Van Agens 4/2/24 Van Agens 4/2/24 Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses Read More Guest User 11/15/23 Guest User 11/15/23 Longhorn Vaccines and Diagnostics Presents Targeted Vaccine Approach for Mycobacterium Tuberculosis with LHNVD-301 Read More Guest User 11/2/23 Guest User 11/2/23 Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023 Read More Guest User 10/16/23 Guest User 10/16/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Durability of LHNVD-105 Universal Influenza Vaccine in Animal Models at IDWeek 2023 Read More Guest User 10/12/23 Guest User 10/12/23 Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses Read More Guest User 10/3/23 Guest User 10/3/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Universal Influenza Vaccine, LHNVD-105, at IDWeek 2023 Read More Guest User 9/27/23 Guest User 9/27/23 New Study Shows Longhorn Vaccines and Diagnostics’ Universal Influenza Vaccine, LHNVD-105, Generates Broad and Durable Immune Responses in Animal Models Read More Guest User 9/25/23 Guest User 9/25/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections Read More Guest User 9/19/23 Guest User 9/19/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress Read More Guest User 8/23/23 Guest User 8/23/23 New Study Shows Longhorn Vaccines and Diagnostics’ PrimeStore Molecular Transport Medium Improves Tuberculosis Testing in Children Read More Media Coverage Guest User 12/19/22 Media Coverage Guest User 12/19/22 9 BioHealth Capital Region Companies That Are Developing Innovative Vaccines and Therapeutics to Combat Global Health Threats Read More Media Coverage Guest User 11/14/22 Media Coverage Guest User 11/14/22 Longhorn recognized as "Diagnostics Company of the Year" Read More Press Release Guest User 11/3/22 Press Release Guest User 11/3/22 Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year” Read More Older Posts
Van Agens 11/13/24 Van Agens 11/13/24 Longhorn Vaccines and Diagnostics Composite Peptide Vaccine Combats Sepsis Related to Antimicrobial Resistant Tuberculosis Read More
Van Agens 10/16/24 Van Agens 10/16/24 Longhorn Vaccines and Diagnostics Highlights New Data for LHNVD-303 its Bacterial Sepsis Vaccine at IDWeek 2024 Read More
Van Agens 9/30/24 Van Agens 9/30/24 Longhorn Vaccines and Diagnostics Collaborates with Institute of Agrifood Research and Technology on Research to Inactivate Swine Fever During Sample Collection Process Read More
Van Agens 7/31/24 Van Agens 7/31/24 Longhorn Vaccines and Diagnostics Provides Mid-Year Progress on Vaccine and Diagnostic Divisions Read More
Van Agens 6/4/24 Van Agens 6/4/24 Longhorn Vaccines and Diagnostics to Showcase PrimeStore® Molecular Transport Medium at Two European Veterinary Health Conferences Read More
Van Agens 4/27/24 Van Agens 4/27/24 Longhorn Vaccines and Diagnostics Presents New Data on its Best-In-Class Infectious Disease Vaccine and Antibody Portfolio at ECCMID 2024 Read More
Van Agens 4/11/24 Van Agens 4/11/24 Longhorn Vaccines and Diagnostics to Present Data on LHNVD-105, a Universal Vaccine Candidate, at ECCMID 2024 Read More
Van Agens 4/2/24 Van Agens 4/2/24 Longhorn Vaccines and Diagnostics Presents at World Vaccine Congress on Advantages of Single Peptide Vaccine for Broad Coverage of Human and Avian Influenza Viruses Read More
Guest User 11/15/23 Guest User 11/15/23 Longhorn Vaccines and Diagnostics Presents Targeted Vaccine Approach for Mycobacterium Tuberculosis with LHNVD-301 Read More
Guest User 11/2/23 Guest User 11/2/23 Longhorn Vaccines and Diagnostics to Present Data on Mycobacterium Tuberculosis Vaccine Candidate, LHNVD-301, at The Union World Conference on Lung Health 2023 Read More
Guest User 10/16/23 Guest User 10/16/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Durability of LHNVD-105 Universal Influenza Vaccine in Animal Models at IDWeek 2023 Read More
Guest User 10/12/23 Guest User 10/12/23 Longhorn Vaccines and Diagnostics Announces Data Showing PrimeStore® Molecular Transport Medium Inactivates High Consequence Animal Viruses Read More
Guest User 10/3/23 Guest User 10/3/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Universal Influenza Vaccine, LHNVD-105, at IDWeek 2023 Read More
Guest User 9/27/23 Guest User 9/27/23 New Study Shows Longhorn Vaccines and Diagnostics’ Universal Influenza Vaccine, LHNVD-105, Generates Broad and Durable Immune Responses in Animal Models Read More
Guest User 9/25/23 Guest User 9/25/23 Longhorn Vaccines and Diagnostics Presents Data Demonstrating Neutralizing Activity of LHNVD-201 for Covid-19 and Influenza Co-Infections Read More
Guest User 9/19/23 Guest User 9/19/23 Longhorn Vaccines and Diagnostics to Present Durability Data of Peptide-Based Vaccine LHNVD-201 for Covid-19 and Influenza Co-Infections at 17th Vaccine Congress Read More
Guest User 8/23/23 Guest User 8/23/23 New Study Shows Longhorn Vaccines and Diagnostics’ PrimeStore Molecular Transport Medium Improves Tuberculosis Testing in Children Read More
Media Coverage Guest User 12/19/22 Media Coverage Guest User 12/19/22 9 BioHealth Capital Region Companies That Are Developing Innovative Vaccines and Therapeutics to Combat Global Health Threats Read More
Media Coverage Guest User 11/14/22 Media Coverage Guest User 11/14/22 Longhorn recognized as "Diagnostics Company of the Year" Read More
Press Release Guest User 11/3/22 Press Release Guest User 11/3/22 Longhorn Vaccines & Diagnostics Recognized as BioTech Breakthrough’s “Diagnostics Company of the Year” Read More
